Received Sep 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y015179 | — |
no adverse event; TE for GARDASIL 9; This spontaneous report was received from a registered medical assistant and refers to a 14-year-old male patient. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 25-Aug-2025, the patient was vaccinated with a dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) Suspension for injection (lot #Y015179, expiration date: 28-Jan-2027) 0.5 mL (0.5mL / once) for prophylaxis. The vaccine underwent a temperature excursion of 47.3 F for 50 minutes and 20 seconds on 08-JUL-2025 and 46.4 F for 25 minutes and 50 seconds on 20-AUG-2025. No additional adverse event was reported.